Market Cap (In USD)
163.15 Thousand
Revenue (In USD)
48.35 Million
Net Income (In USD)
-3.81 Million
Avg. Volume
12.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.29-16.18
- PE
- -
- EPS
- -
- Beta Value
- -0.749
- ISIN
- US14068E2081
- CUSIP
- 14068E208
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Michael M. Toporek III
- Employee Count
- -
- Website
- https://www.capstonethx.com
- Ipo Date
- 1993-01-28
- Details
- Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
More Stocks
-
NXMRNextMart, Inc.
NXMR
-
NBTRFNobel Resources Corp.
NBTRF
-
BPP-R
-
IPXX
-
DCMDCM Limited
DCM
-
SNG
-
WHITEORGWhite Organic Agro Limited
WHITEORG
-
BUR